A novel differential diagnosis algorithm for chronic lymphocytic leukemia using immunophenotyping with flow cytometry
Zehra Narli Ozdemir1, Mesude Falay2, Ayhan Parmaksiz3
1Ankara City Hospital, Ankara, Turkey.
Insights
A new algorithm using flow cytometry improves chronic lymphocytic leukemia (CLL) diagnosis. This method accurately distinguishes CLL from other lymphoproliferative disorders (LPDs) using key markers.
Area of Science:
- Hematology
- Immunophenotyping
- Flow Cytometry
Background:
- Accurate diagnosis of chronic lymphocytic leukemia (CLL) is crucial, especially in ambiguous cases.
- Immunophenotyping via flow cytometry is a key diagnostic tool.
- A clinical decision algorithm can enhance diagnostic accuracy for CLL.
Purpose of the Study:
- To develop a novel differential diagnosis algorithm for CLL using flow cytometry immunophenotyping.
- To improve the accuracy of CLL diagnosis and differentiation from other lymphoproliferative disorders (LPDs).
Main Methods:
- Utilized a hierarchical logistic regression model (Backward LR) to construct a predictive algorithm.
- Included 302 patients: 220 with CLL and 82 with other B-cell LPDs.
- Analyzed specific immunophenotypic markers including CD5, CD43, CD81, ROR1, CD23, CD79b, FMC7, sIg, and CD200.
Main Results:
- The Backward LR model identified CD5, CD23, CD200, and CD81 as significant variables.
- Increased expression of CD5, CD23, and CD200, and weak CD81 expression, correlated with CLL diagnosis (p < 0.05).
- The algorithm achieved 95.27% sensitivity and 91.46% specificity, with an overall correctness rate of 95.7%.
Conclusions:
- A novel diagnostic algorithm utilizing four key markers (CD81, CD5, CD23, CD200) was developed.
- The algorithm demonstrates high sensitivity and specificity for CLL diagnosis.
- This tool effectively distinguishes CLL from other LPDs.
Introduction:
The availability of a clinical decision algorithm for diagnosis of chronic lymphocytic leukemia (CLL) may greatly contribute to the diagnosis of CLL, particularly in cases with ambiguous immunophenotypes. Herein we propose a novel differential diagnosis algorithm for the CLL diagnosis using immunophenotyping with flow cytometry.
Methods:
The hierarchical logistic regression model (Backward LR) was used to build a predictive algorithm for the diagnosis of CLL, differentiated from other lymphoproliferative disorders (LPDs).
Results:
A total of 302 patients, of whom 220 (72.8%) had CLL and 82 (27.2%), B-cell lymphoproliferative disorders other than CLL, were included in the study. The Backward LR model comprised the variables CD5, CD43, CD81, ROR1, CD23, CD79b, FMC7, sIg and CD200 in the model development process. The weak expression of CD81 and increased intensity of expression in markers CD5, CD23 and CD200 increased the probability of CLL diagnosis, (p < 0.05). The odd ratio for CD5, C23, CD200 and CD81 was 1.088 (1.050 - 1.126), 1.044 (1.012 - 1.077), 1.039 (1.007 - 1.072) and 0.946 (0.921 - 0.970) [95% C.I.], respectively. Our model provided a novel diagnostic algorithm with 95.27% of sensitivity and 91.46% of specificity. The model prediction for 97.3% (214) of 220 patients diagnosed with CLL, was CLL and for 91.5% (75) of 82 patients diagnosed with an LPD other than CLL, was others. The cases were correctly classified as CLL and others with a 95.7% correctness rate.
Conclusions:
Our model highlighting 4 markers (CD81, CD5, CD23 and CD200) provided high sensitivity and specificity in the CLL diagnosis and in distinguishing of CLL among other LPDs.
More Related Videos
10:18From a 2DE-Gel Spot to Protein Function: Lesson Learned From HS1 in Chronic Lymphocytic Leukemia
Published on: October 19, 2014
09:57Comprehensive Protocol to Sample and Process Bone Marrow for Measuring Measurable Residual Disease and Leukemic Stem Cells in Acute Myeloid Leukemia
Published on: March 5, 2018